Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Focusing on cures

Payers, manufacturers, patients and academics are piloting financing options for curative therapies

February 1, 2019 10:01 PM UTC

A Massachusetts Institute of Technology-led consortium is finalizing pilot programs that are intended to serve as models for overcoming two major hurdles to implementing performance-based contracts for curative therapies in the United States. The goal is to test a series of financial engineering concepts the consortium calls “precision financing.”

One pilot seeks to make multiyear performance-based annuity contracts portable, so they can be handed off when patients who are receiving potentially curative therapies switch insurance companies. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article